Xeris Biopharma Holdings, Inc. (XERS)
6.58
-0.03
(-0.45%)
USD |
NASDAQ |
Feb 23, 16:00
6.57
-0.01
(-0.15%)
After-Hours: 19:59
Xeris Biopharma Holdings EPS Diluted (Quarterly) : 0.0035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.621M |
| Revenue (Quarterly) | 74.38M |
| Total Expenses (Quarterly) | 73.76M |
| Enterprise Value | 1.258B |
| Gross Profit Margin (Quarterly) | 81.57% |
| Profit Margin (Quarterly) | 0.83% |
| Earnings Yield | -1.57% |
| Operating Earnings Yield | 0.93% |
| Normalized Earnings Yield | -1.571 |